Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-26

FDA Approved: DALBAVANCIN — Original Application (Long Grove Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a generic dalbavancin hydrochloride product from Long Grove Pharmaceuticals, LLC. It is indicated for acute bacterial skin and skin structure i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DALBAVANCIN HYDROCHLORIDE (dalbavancin hydrochloride)

Snippet

ORIG AP for DALBAVANCIN (DALBAVANCIN HYDROCHLORIDE)